{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:37:35Z","timestamp":1784677055309,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930089"],"award-info":[{"award-number":["81930089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672089"],"award-info":[{"award-number":["81672089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630082"],"award-info":[{"award-number":["81630082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Isoleucyl-tRNA synthetase (IARS) catalyzes isoleucine to the corresponding tRNA, maintaining the accuracy of gene translation. Its role in psoriasis has been not investigated so far. In this study, we aimed to investigate the mechanisms underlying the efficacy of IARS inhibitor, mupirocin, treatment for psoriasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of IARS was determined by immunofluorescence, Western blot and qRT-PCR in normal healthy control- and psoriatic human skin. An imiquimod (IMQ) -induced psoriasis-like skin disease model was used to study the phenotypes changed by an IARS inhibitor, mupirocin (MUP). Endotypes were analyzed by RNA-seq, R&amp;D Luminex multi-factor technique, ELISA, immunofluorescence and flow cytometry. Additionally, the effect of MUP on epidermal keratinocytes (KCs) were conducted in-vitro in primary cultured human KCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found the expression of IARS was higher in psoriatic skin than in healthy controls. In IMQ-induced psoriasis-like C57BL\/6\u00a0J mouse model, MUP reversed IMQ-induced keratinocytes proliferation, expression of inflammatory cytokines and infiltration of immune cells. Furthermore, in cultured human keratinocytes, MUP inhibited proliferation, but promoted apoptosis, which may be related with STAT3 signaling pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our finding of blocking the infiltration of immune cells by inhibiting the formation of IARS, could be one mechanism to explain the effect of MUP in the treatment of psoriasis. Developing strategies targeting suppression IARS should open new perspectives for the treatment of psoriasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n                \n              <\/jats:sec>","DOI":"10.1186\/s12964-022-00995-0","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:13:11Z","timestamp":1669180391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase"],"prefix":"10.1186","volume":"20","author":[{"given":"Bing-Xi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Zhe","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Landeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-Chang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"995_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","volume":"60","author":"SK Kurd","year":"2009","unstructured":"Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003\u20132004. J Am Acad Dermatol. 2009;60:218\u201324.","journal-title":"J Am Acad Dermatol"},{"key":"995_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","volume":"70","author":"TD Rachakonda","year":"2014","unstructured":"Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"995_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945\u201360.","journal-title":"JAMA"},{"key":"995_CR4","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nat Rev Dis Prim. 2016;2:16082.","journal-title":"Nat Rev Dis Prim"},{"key":"995_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"995_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5114\/ada.2021.106197","volume":"38","author":"M Mazur","year":"2021","unstructured":"Mazur M, Tomczak H, Lodyga M, Czajkowski R, \u017baba R, Adamski Z. The microbiome of the human skin and its variability in psoriasis and atopic dermatitis. Postepy Dermatol Alergol. 2021;38:205\u20139.","journal-title":"Postepy Dermatol Alergol"},{"key":"995_CR7","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","volume":"9","author":"C Albanesi","year":"2018","unstructured":"Albanesi C, Madonna S, Gisondi P, Girolomoni G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front Immunol. 2018;9:1549.","journal-title":"Front Immunol"},{"key":"995_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","volume":"394","author":"K Reich","year":"2019","unstructured":"Reich K, Armstrong AW, Langley RG, Flavin S, Randazzo B, Li S, Hsu MC, Branigan P, Blauvelt A. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019;394:831\u20139.","journal-title":"Lancet"},{"key":"995_CR9","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018;201:1605\u201313.","journal-title":"J Immunol"},{"key":"995_CR10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191397","author":"I Prinz","year":"2020","unstructured":"Prinz I, Sandrock I, Mrowietz U. Interleukin-17 cytokines: effectors and targets in psoriasis-A breakthrough in understanding and treatment. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191397.","journal-title":"J Exp Med"},{"key":"995_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/jid.2013.500","volume":"134","author":"K Taniguchi","year":"2014","unstructured":"Taniguchi K, Arima K, Masuoka M, Ohta S, Shiraishi H, Ontsuka K, Suzuki S, Inamitsu M, Yamamoto KI, Simmons O, et al. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1alpha\/IL-6 loop. J Invest Dermatol. 2014;134:1295\u2013304.","journal-title":"J Invest Dermatol"},{"key":"995_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386:983\u201394.","journal-title":"Lancet"},{"key":"995_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268\u201373.","journal-title":"Science"},{"key":"995_CR14","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-019-12253-y","volume":"10","author":"N Fyhrquist","year":"2019","unstructured":"Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, Skoog T, Jules-Clement G, Feld M, Barrientos-Somarribas M, Sinkko H, et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10:4703.","journal-title":"Nat Commun"},{"key":"995_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bjd.17989","volume":"181","author":"EA Langan","year":"2019","unstructured":"Langan EA, K\u00fcnstner A, Miodovnik M, Zillikens D, Tha\u00e7i D, Baines JF, Ibrahim SM, Solbach W, Knobloch JK. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. Br J Dermatol. 2019;181:1254\u201364.","journal-title":"Br J Dermatol"},{"key":"995_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.biopha.2018.10.131","volume":"109","author":"S Khoshnood","year":"2019","unstructured":"Khoshnood S, Heidary M, Asadi A, Soleimani S, Motahar M, Savari M, Saki M, Abdi M. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother. 2019;109:1809\u201318.","journal-title":"Biomed Pharmacother"},{"key":"995_CR17","doi-asserted-by":"publisher","first-page":"47387","DOI":"10.1074\/jbc.M109089200","volume":"276","author":"T Nakama","year":"2001","unstructured":"Nakama T, Nureki O, Yokoyama S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J Biol Chem. 2001;276:47387\u201393.","journal-title":"J Biol Chem"},{"key":"995_CR18","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1074\/jbc.REV118.002956","volume":"294","author":"CS Francklyn","year":"2019","unstructured":"Francklyn CS, Mullen P. Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics. J Biol Chem. 2019;294:5365\u201385.","journal-title":"J Biol Chem"},{"key":"995_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev.biochem.69.1.617","volume":"69","author":"M Ibba","year":"2000","unstructured":"Ibba M, Soll D. Aminoacyl-tRNA synthesis. Annu Rev Biochem. 2000;69:617\u201350.","journal-title":"Annu Rev Biochem"},{"key":"995_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","volume":"18","author":"NH Kwon","year":"2019","unstructured":"Kwon NH, Fox PL, Kim S. Aminoacyl-tRNA synthetases as therapeutic targets. Nat Rev Drug Discov. 2019;18:629\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"995_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1161\/ATVBAHA.115.307087","volume":"36","author":"D Castranova","year":"2016","unstructured":"Castranova D, Davis AE, Lo BD, Miller MF, Paukstelis PJ, Swift MR, Pham VN, Torres-Vazquez J, Bell K, Shaw KM, et al. Aminoacyl-transfer RNA synthetase deficiency promotes angiogenesis via the unfolded protein response pathway. Arterioscler Thromb Vasc Biol. 2016;36:655\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"995_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/hmg\/ddr440","volume":"21","author":"E Perli","year":"2012","unstructured":"Perli E, Giordano C, Tuppen HA, Montopoli M, Montanari A, Orlandi M, Pisano A, Catanzaro D, Caparrotta L, Musumeci B, et al. Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy. Hum Mol Genet. 2012;21:85\u2013100.","journal-title":"Hum Mol Genet"},{"key":"995_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199\u2013204.","journal-title":"Nat Genet"},{"key":"995_CR24","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00018-012-1255-3","volume":"70","author":"XY Man","year":"2013","unstructured":"Man XY, Li W, Chen JQ, Zhou J, Landeck L, Zhang KH, Mu Z, Li CM, Cai SQ, Zheng M. Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes. Cell Mol Life Sci. 2013;70:2205\u201320.","journal-title":"Cell Mol Life Sci"},{"key":"995_CR25","first-page":"289","volume":"18","author":"SQ Cai","year":"2014","unstructured":"Cai SQ, Dou TT, Li W, Li SQ, Chen JQ, Zhou J, Zheng M, Man XY. Involvement of pituitary tumor transforming gene 1 in psoriasis, seborrheic keratosis, and skin tumors. Discov Med. 2014;18:289\u201399.","journal-title":"Discov Med"},{"key":"995_CR26","doi-asserted-by":"publisher","first-page":"e0190051","DOI":"10.1371\/journal.pone.0190051","volume":"12","author":"M Min","year":"2017","unstructured":"Min M, Yan BX, Wang P, Landeck L, Chen JQ, Li W, Cai SQ, Zheng M, Man XY. Rottlerin as a therapeutic approach in psoriasis: evidence from in vitro and in vivo studies. PLoS One. 2017;12:e0190051.","journal-title":"PLoS One"},{"key":"995_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/wound.2018.0890","volume":"9","author":"BB Yang","year":"2020","unstructured":"Yang BB, Zheng YX, Yan BX, Cao HL, Landeck L, Chen JQ, Li W, Min M, Wang P, Cai SQ, et al. Suppressor of fused inhibits skin wound healing. Adv Wound Care (New Rochelle). 2020;9:233\u201344.","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"995_CR28","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","volume":"192","author":"CB Russell","year":"2014","unstructured":"Russell CB, Rand H, Bigler J, Kerkof K, Timour M, Bautista E, Krueger JG, Salinger DH, Welcher AA, Martin DA. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol. 2014;192:3828\u201336.","journal-title":"J Immunol"},{"key":"995_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.jid.5700072","volume":"126","author":"A Wetzel","year":"2006","unstructured":"Wetzel A, Wetzig T, Haustein UF, Sticherling M, Anderegg U, Simon JC, Saalbach A. Increased neutrophil adherence in psoriasis: role of the human endothelial cell receptor Thy-1 (CD90). J Invest Dermatol. 2006;126:441\u201352.","journal-title":"J Invest Dermatol"},{"key":"995_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaad.2018.07.059","volume":"82","author":"SR Feldman","year":"2020","unstructured":"Feldman SR. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 2020;82:256\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"995_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","volume":"70","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, Paul CF, Puig L, Reich K, van de Kerkhof PC. Patient perspectives in the management of psoriasis: results from the population-based multinational assessment of psoriasis and psoriatic arthritis survey. J Am Acad Dermatol. 2014;70:871\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"995_CR32","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","volume":"19","author":"T Dainichi","year":"2018","unstructured":"Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, Kabashima K. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol. 2018;19:1286\u201398.","journal-title":"Nat Immunol"},{"key":"995_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.23736\/S0392-0488.18.06202-8","volume":"154","author":"K Furue","year":"2019","unstructured":"Furue K, Ito T, Tsuji G, Kadono T, Furue M. Psoriasis and the TNF\/IL23\/IL17 axis. G Ital Dermatol Venereol. 2019;154:418\u201324.","journal-title":"G Ital Dermatol Venereol"},{"key":"995_CR34","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.3390\/ijms21186604","volume":"21","author":"Y Sato","year":"2020","unstructured":"Sato Y, Ogawa E, Okuyama R. Role of innate immune cells in psoriasis. Int J Mol Sci. 2020;21:6604. https:\/\/doi.org\/10.3390\/ijms21186604.","journal-title":"Int J Mol Sci."},{"key":"995_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2340\/00015555-3066","volume":"99","author":"L Pasquali","year":"2019","unstructured":"Pasquali L, Srivastava A, Meisgen F, Das Mahapatra K, Xia P, Xu Landen N, Pivarcsi A, Sonkoly E. The keratinocyte transcriptome in psoriasis: pathways related to immune responses, cell cycle and keratinization. Acta Derm Venereol. 2019;99:196\u2013205.","journal-title":"Acta Derm Venereol"},{"key":"995_CR36","doi-asserted-by":"publisher","first-page":"e24549","DOI":"10.1097\/MD.0000000000024549","volume":"100","author":"N Liu","year":"2021","unstructured":"Liu N, Su D, Liu K, Liu B, Wang S, Zhang X. The effects of IL-17\/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: a protocol for systematic review and meta analysis. Medicine (Baltimore). 2021;100:e24549.","journal-title":"Medicine (Baltimore)"},{"key":"995_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI130740","author":"HL Chen","year":"2021","unstructured":"Chen HL, Lo CH, Huang CC, Lu MP, Hu PY, Chen CS, Chueh DY, Chen P, Lin TN, Lo YH, et al. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI130740.","journal-title":"J Clin Invest"},{"key":"995_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/medicina56120719","volume":"56","author":"E Munoz-Aceituno","year":"2020","unstructured":"Munoz-Aceituno E, Martos-Cabrera L, Ovejero-Benito MC, Reolid A, Abad-Santos F, Dauden E. Pharmacogenetics update on biologic therapy in psoriasis. Medicina (Kaunas). 2020;56:719. https:\/\/doi.org\/10.3390\/medicina56120719.","journal-title":"Medicina (Kaunas)."},{"key":"995_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","volume":"19","author":"E Calautti","year":"2018","unstructured":"Calautti E, Avalle L, Poli V. Psoriasis: a STAT3-centric view. Int J Mol Sci. 2018;19:171. https:\/\/doi.org\/10.3390\/ijms19010171.","journal-title":"Int J Mol Sci."},{"key":"995_CR40","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/diagnostics11101903","volume":"11","author":"M Kishimoto","year":"2021","unstructured":"Kishimoto M, Komine M, Sashikawa-Kimura M, Ansary TM, Kamiya K, Sugai J, Mieno M, Kawata H, Sekimoto R, Fukushima N, Ohtsuki M. STAT3 activation in psoriasis and cancers. Diagnostics (Basel). 2021;11:1903. https:\/\/doi.org\/10.3390\/diagnostics11101903.","journal-title":"Diagnostics (Basel)."},{"key":"995_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.14112","volume":"45","author":"K Nakajima","year":"2018","unstructured":"Nakajima K, Sano S. Mouse models of psoriasis and their relevance. J Dermatol. 2018;45:252\u201363.","journal-title":"J Dermatol"},{"key":"995_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","volume":"11","author":"S Sano","year":"2005","unstructured":"Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11:43\u20139.","journal-title":"Nat Med"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-022-00995-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-022-00995-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-022-00995-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:18:47Z","timestamp":1669180727000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-022-00995-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1186\/s12964-022-00995-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Animal Care and Use Committee of Second Affiliated Hospital, Zhejiang University School of Medicine and the Institutional Review Board at Second Affiliated Hospital, Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}